share_log

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga Real-time News ·  Jan 20, 2023 08:07

Gainers

  • Akanda (NASDAQ:AKAN) stock increased by 31.3% to $0.21 during Friday's pre-market session. The market value of their outstanding shares is at $7.2 million.
  • ContraFect (NASDAQ:CFRX) shares moved upwards by 21.4% to $0.11. The market value of their outstanding shares is at $4.9 million.
  • Lucira Health (NASDAQ:LHDX) shares moved upwards by 20.04% to $0.32. The company's market cap stands at $12.7 million.
  • Freeline Therapeutics (NASDAQ:FRLN) shares increased by 15.43% to $0.58. The company's market cap stands at $37.5 million.
  • Monopar Therapeutics (NASDAQ:MNPR) shares moved upwards by 14.03% to $3.25. The market value of their outstanding shares is at $41.9 million.
  • Salarius Pharmaceuticals (NASDAQ:SLRX) shares increased by 13.68% to $4.07. The market value of their outstanding shares is at $9.2 million.

Losers

  • Synlogic (NASDAQ:SYBX) shares fell 15.0% to $0.85 during Friday's pre-market session. The market value of their outstanding shares is at $59.9 million.
  • NexImmune (NASDAQ:NEXI) shares decreased by 13.87% to $0.31. The company's market cap stands at $8.0 million.
  • Sunshine Biopharma (NASDAQ:SBFM) shares fell 12.37% to $0.85. The market value of their outstanding shares is at $19.1 million.
  • Celyad Oncology (NASDAQ:CYAD) stock decreased by 11.37% to $1.95. The company's market cap stands at $44.0 million.
  • Apexigen (NASDAQ:APGN) stock decreased by 9.85% to $1.74. The market value of their outstanding shares is at $39.2 million.
  • TC BioPharm (Holdings) (NASDAQ:TCBP) stock fell 9.24% to $4.72. The company's market cap stands at $187.6 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment